Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss
Journal of Reproductive Immunology · 2024
DOI: 10.1016/j.jri.2024.104322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproductive Immunology, 2024. Verfasst von Fangxiang Mu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730030, China. Hauptthemen laut MEDLINE: Immunoglobulins, Intravenous, Abortion, Habitual, Live Birth, Birth Rate. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lanzhou University Second Hospital, Lanzhou University.
Abstract (Originalsprache)
This real-world study aimed to assess the clinical efficacy and safety of intravenous immunoglobulin (IVIG) in treating unexplained recurrent pregnancy loss (uRPL) patients. A total of 238 patients with uRPL were enrolled in this retrospective study. According to the treatment, patients were assigned into treatment group (n=184, receiving IVIG+low molecular weight heparin [LMWH]) and control group (n=54, only LMWH). The primary outcome was the live birth rates (LBR) after 24 weeks of gestation. In addition, we performed subgroup analyses to assess the LBR in uRPL patients with age (≥30 years or
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730030, China.
- Department of Reproductive Medicine, Lanzhou University Second Hospital, Lanzhou 730030, China. Electronic address: ery_fwang@lzu.edu.cn.
Förderung
- Lanzhou University Second Hospital
- Lanzhou University
Zitieren
APA
Mu, F., Huo, H., Wang, M., Liu, L., & Wang, F. (2024). Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss. Journal of Reproductive Immunology. https://doi.org/10.1016/j.jri.2024.104322
Vancouver
Mu F, Huo H, Wang M, Liu L, Wang F. Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss. Journal of Reproductive Immunology. 2024. doi:10.1016/j.jri.2024.104322
BibTeX
@article{Mu2024,
author = {Mu, Fangxiang and Huo, Huyan and Wang, Mei and Liu, Ling and Wang, Fang},
title = {Intravenous immunoglobulin improves live birth rates in patients with unexplained recurrent pregnancy loss},
journal = {Journal of Reproductive Immunology},
year = {2024},
doi = {10.1016/j.jri.2024.104322}
}
EUVIMED